TINAVI :: Surgical Robots & Related Intelligent Medical Technologies

TINAVI (Beijing Tinavi Medical Technologies Co., Ltd.) is a leading Chinese high-tech company specializing in orthopedic surgical robots and related intelligent medical technologies. Founded in 2005 and listed on the STAR Market in 2020 (stock code: 688277), TINAVI is recognized as a pioneer in medical robotics in China and the fifth company worldwide to obtain a medical robot registration license. The company focuses on the independent research, development, production, marketing, and clinical application of orthopedic surgical robots, aiming to advance precision and intelligent orthopedics.

TINAVI’s flagship product line revolves around the TiRobot series, particularly the advanced TiRobot II. This versatile orthopedic robotic system supports a wide range of procedures across spine, pelvis, trauma, and joint replacement surgeries (including total knee arthroplasty). It integrates advanced navigation, real-time 3D imaging, active infrared tracking, and a multi-functional robotic arm to achieve sub-millimeter clinical accuracy (often ≤1.5 mm). Key features include optimized workflows for efficiency, enhanced safety mechanisms like force feedback and braking systems, and support for minimally invasive techniques.

The robot assists surgeons in preoperative planning, intraoperative navigation, and precise screw placement or implant positioning, significantly reducing radiation exposure, improving accuracy compared to traditional or O-arm navigation methods, and lowering complication risks. TINAVI also offers supporting products such as specialized instruments, a 5G remote surgery system for telesurgery capabilities, and robotics-guided orthopedic systems. As of early 2025, TiRobot systems had assisted in over 120,000 surgeries across more than 200 medical institutions in China.

Beyond hardware, TINAVI emphasizes ecosystem development through TINAVI College (TianJi College), which provides training platforms, academic exchanges, and surgeon education on robotic applications. The company actively participates in national robot standardization efforts and has contributed to clinical guidelines for orthopedic robot surgery. It holds multiple certifications, including NMPA approvals, CE marking, and CSA certification, and continues expanding internationally while investing in AI integration, software planning tools, and smart medical center projects.

TINAVI represents China’s growing strength in medtech innovation, bridging robotics, imaging, and clinical needs to make complex orthopedic surgeries safer, more precise, and more accessible. Its solutions support the shift toward intelligent, data-driven healthcare in the era of precision medicine.